Neurology-focused company Flow Neuroscience has purchased fellow med tech company Halo Neuroscience for an undisclosed sum.
The pair both focus in brain stimulation technology to improve outcomes. However, historically Flow has zeroed in on the depression space, and Halo was best known for its movement performance enhancements.
As part of the deal Flow will be purchasing Halo’s technology, R&...
Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s disease symptoms.
By now targeting the internal globus pallidus alongside the subthalamic nucleus and ventral intermediate nucleus, the company says that its system “is now the only directional DBS...
This morning neurology-focused health startup Flow announced that it landed a $1.5 million investment. This latest round was led by Khosla Ventures.
WHAT THEY DO
The Swedish startup is focused on treating and supporting users with depression. Flow is a two-part system including a brain stimulation headset and a therapy app. When the user puts on the device, it delivers electrical signals to...
This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company. The two companies announced they have been granted the rights to multiple international digital health patents. Akili revealed they are developing a technology aimed at using neural...
